These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Alzheimer's disease: advance in researches on Beta-amyloid protein]. Liu J; Bao Y; An L Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Jun; 20(2):371-4. PubMed ID: 12856622 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: a critical appraisal. Sayre LM; Zagorski MG; Surewicz WK; Krafft GA; Perry G Chem Res Toxicol; 1997 May; 10(5):518-26. PubMed ID: 9168248 [No Abstract] [Full Text] [Related]
4. [Significance of intracellular A beta in Alzheimer's disease]. Tabira T Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Oct; 22(5):175-80. PubMed ID: 12451689 [TBL] [Abstract][Full Text] [Related]
5. Amyloid imaging in Alzheimer's disease. Nordberg A Neuropsychologia; 2008; 46(6):1636-41. PubMed ID: 18468648 [TBL] [Abstract][Full Text] [Related]
6. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease. Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398 [TBL] [Abstract][Full Text] [Related]
7. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease. Wyss-Coray T; Masliah E; Mallory M; McConlogue L; Johnson-Wood K; Lin C; Mucke L Nature; 1997 Oct; 389(6651):603-6. PubMed ID: 9335500 [TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity. Roy S; Rauk A Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129 [TBL] [Abstract][Full Text] [Related]
9. Amyloid beta protein starting pyroglutamate at position 3 is a major component of the amyloid deposits in the Alzheimer's disease brain. Harigaya Y; Saido TC; Eckman CB; Prada CM; Shoji M; Younkin SG Biochem Biophys Res Commun; 2000 Sep; 276(2):422-7. PubMed ID: 11027491 [TBL] [Abstract][Full Text] [Related]
10. Redox proteomics identification of oxidatively modified proteins in Alzheimer's disease brain and in vivo and in vitro models of AD centered around Abeta(1-42). Sultana R; Perluigi M; Butterfield DA J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 833(1):3-11. PubMed ID: 16236561 [TBL] [Abstract][Full Text] [Related]
11. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910 [TBL] [Abstract][Full Text] [Related]
12. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies. Kirkitadze MD; Bitan G; Teplow DB J Neurosci Res; 2002 Sep; 69(5):567-77. PubMed ID: 12210822 [TBL] [Abstract][Full Text] [Related]
13. Deposition of monomeric, not oligomeric, Abeta mediates growth of Alzheimer's disease amyloid plaques in human brain preparations. Tseng BP; Esler WP; Clish CB; Stimson ER; Ghilardi JR; Vinters HV; Mantyh PW; Lee JP; Maggio JE Biochemistry; 1999 Aug; 38(32):10424-31. PubMed ID: 10441137 [TBL] [Abstract][Full Text] [Related]
14. Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. DeMattos RB; Bales KR; Cummins DJ; Paul SM; Holtzman DM Science; 2002 Mar; 295(5563):2264-7. PubMed ID: 11910111 [TBL] [Abstract][Full Text] [Related]
15. Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain. Blomqvist ME; Chalmers K; Andreasen N; Bogdanovic N; Wilcock GK; Cairns NJ; Feuk L; Brookes AJ; Love S; Blennow K; Kehoe PG; Prince JA Neurobiol Aging; 2005 Jun; 26(6):795-802. PubMed ID: 15718037 [TBL] [Abstract][Full Text] [Related]
16. Co-accumulation of vascular endothelial growth factor with beta-amyloid in the brain of patients with Alzheimer's disease. Yang SP; Bae DG; Kang HJ; Gwag BJ; Gho YS; Chae CB Neurobiol Aging; 2004 Mar; 25(3):283-90. PubMed ID: 15123332 [TBL] [Abstract][Full Text] [Related]
17. Activation barriers to structural transition determine deposition rates of Alzheimer's disease a beta amyloid. Esler WP; Felix AM; Stimson ER; Lachenmann MJ; Ghilardi JR; Lu YA; Vinters HV; Mantyh PW; Lee JP; Maggio JE J Struct Biol; 2000 Jun; 130(2-3):174-83. PubMed ID: 10940224 [TBL] [Abstract][Full Text] [Related]
18. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Hardy J; Selkoe DJ Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773 [TBL] [Abstract][Full Text] [Related]
19. Structure of beta-amyloid fibrils and its relevance to their neurotoxicity: implications for the pathogenesis of Alzheimer's disease. Irie K; Murakami K; Masuda Y; Morimoto A; Ohigashi H; Ohashi R; Takegoshi K; Nagao M; Shimizu T; Shirasawa T J Biosci Bioeng; 2005 May; 99(5):437-47. PubMed ID: 16233815 [TBL] [Abstract][Full Text] [Related]
20. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Donahue JE; Flaherty SL; Johanson CE; Duncan JA; Silverberg GD; Miller MC; Tavares R; Yang W; Wu Q; Sabo E; Hovanesian V; Stopa EG Acta Neuropathol; 2006 Oct; 112(4):405-15. PubMed ID: 16865397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]